A Look At Sotera Health’s Valuation As Earnings Beat And Board Changes Reset Expectations

Simply Wall St.03-20

AdvertisementWhy this earnings beat and board reshuffle matter for Sotera Health (SHC) Sotera Health (SHC) recently reported Q4 results that came in ahead of analyst expectations, supported by demand ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2620738904?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","is_english":true,"pubTime":"2026-03-20 19:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620738904","market":"hk","top_or_hot":-1,"title":"A Look At Sotera Health’s Valuation As Earnings Beat And Board Changes Reset Expectations","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementWhy this earnings beat and board reshuffle matter for Sotera Health (SHC) Sotera Health (SHC) recently reported Q4 results that came in ahead of analyst expectations, supported by demand ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-shc/sotera-health/news/a-look-at-sotera-healths-valuation-as-earnings-beat-and-boar\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Sotera Health’s Valuation As Earnings Beat And Board Changes Reset Expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Sotera Health’s Valuation As Earnings Beat And Board Changes Reset Expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-20 19:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-shc/sotera-health/news/a-look-at-sotera-healths-valuation-as-earnings-beat-and-boar><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementWhy this earnings beat and board reshuffle matter for Sotera Health (SHC) Sotera Health (SHC) recently reported Q4 results that came in ahead of analyst expectations, supported by demand ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-shc/sotera-health/news/a-look-at-sotera-healths-valuation-as-earnings-beat-and-boar\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-shc/sotera-health/news/a-look-at-sotera-healths-valuation-as-earnings-beat-and-boar","article_id":"2620738904","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-shc/sotera-health/news/a-look-at-sotera-healths-valuation-as-earnings-beat-and-boar","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2620738904","pubTimestamp":1774005008,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Why this earnings beat and board reshuffle matter for Sotera Health (SHC)\nSotera Health (SHC) recently reported Q4 results that came in ahead of analyst expectations, supported by demand for its mission critical services and disciplined financial management, while also refreshing its board with a new independent director.\nSee our latest analysis for Sotera Health.\nAt a share price of US$13.56, Sotera Health has seen a 1 month share price return of around 21% decline and a 90 day share price...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4121":"生命科学工具和服务","SHC":"Sotera Health Company"},"translate_title":"随着盈利超出预期和董事会变动重置预期，Sotera Health的估值一览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SHC":1},"content_text":"AdvertisementWhy this earnings beat and board reshuffle matter for Sotera Health (SHC) Sotera Health (SHC) recently reported Q4 results that came in ahead of analyst expectations, supported by demand for its mission critical services and disciplined financial management, while also refreshing its board with a new independent director. See our latest analysis for Sotera Health. At a share price of US$13.56, Sotera Health has seen a 1 month share price return of around 21% decline and a 90 day share price return of roughly 21% decline, while its 1 year total shareholder return is 13.28%. Recent short term momentum therefore contrasts with a stronger 12 month outcome, as investors weigh the Q4 beat and the arrival of a finance focused independent director against earlier gains. If this kind of governance and earnings story has your attention, it can be useful to widen the lens and see which other healthcare names are using AI to reshape diagnostics and treatment, starting with our 35 healthcare AI stocks With SHC trading at US$13.56, a 1 year total return of 13.28% and a quoted discount to both analyst targets and intrinsic value, investors now face the key question: is this earnings and governance reset still undervalued or already priced for future growth? Most Popular Narrative: 34.7% Undervalued On the most followed narrative, Sotera Health's fair value of $20.75 sits well above the last close at $13.56. This sets up a valuation story built on earnings power, margins and cash generation under a higher discount rate of 9.02%.  The analysts have a consensus price target of $16.0 for Sotera Health based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $17.0, and the most bearish reporting a price target of just $14.0.  Read the complete narrative. Want to see what is sitting behind that higher fair value than the consensus target? The narrative leans on rising margins, firm revenue assumptions and a future earnings multiple that still prices in discipline. On this narrative, Sotera Health screens as undervalued because the fair value of $20.75, built on refreshed revenue growth, profit margin and future P/E assumptions under a 9.02% discount rate, remains well above the current $13.56 share price while also sitting above the $20.75 analyst price target now referenced in the Simply Wall St company report. Result: Fair Value of $20.75 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, this depends on regulatory and legal risks around ethylene oxide emissions, as well as ongoing high compliance and capital spending that could pressure margins and cash generation. Find out about the key risks to this Sotera Health narrative. Next Steps Given this mix of concern and optimism around Sotera Health, it makes sense to look at the full picture and decide where you stand. To weigh both the upside potential and the caution flags side by side, take a closer look at the 4 key rewards and 2 important warning signs Looking for more investment ideas? If Sotera Health has sharpened your focus, do not stop here. The same tools that surfaced this story can help you spot your next opportunity.  Hunt for quality at a discount with the 49 high quality undervalued stocks that filters for companies combining solid fundamentals with prices that may sit below their intrinsic worth. Prioritise resilience by scanning the 72 resilient stocks with low risk scores and focus on businesses with lower risk profiles that could help smooth out a volatile portfolio. Uncover lesser known opportunities through the screener containing 25 high quality undiscovered gems and see which underfollowed names match your preferred fundamentals before other investors catch on.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2620738904","isCrawlerRequest":true}